Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Opinion
Video
Vitiligo Treatment Paradigms: Clinician Experiences with Topical Ruxolitinib and Access Challenges
Author(s):
Panelists discuss how their clinical experiences with topical ruxolitinib are shaping new treatment paradigms for vitiligo, while also addressing challenges related to medication access.
EP: 1.Vitiligo Insights: Case-Based Discussion on Delayed Treatment, Psychosocial Impact, and Evolving Approaches for SOC Patients
EP: 2.Case-Based Discussion on Adherence, Adjunctive Therapy, and Simplifying Complex Regimens for Patients With Vitiligo
EP: 3.Exploring Phototherapy, Combination Therapy, and Patient-Centered Approaches to Improve QOL for Patients with Vitiligo
EP: 4.Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management
EP: 5.Exploring Efficacy, Novel Mechanisms, and Patient Engagement in the Management of Vitiligo
Now Viewing
EP: 6.Vitiligo Treatment Paradigms: Clinician Experiences with Topical Ruxolitinib and Access Challenges
EP: 7.Optimizing Vitiligo Management: Key Takeaways on Treatment Cycling and Ruxolitinib Use
Related Videos
Related Content
